Cardiogenesis - Investment FAQ's



 

General Questions

  1. Who is Cardiogenesis' transfer agent and how does a registered shareholder contact the agent regarding account information?

Answers

General Questions



1.   Who is Cardiogenesis’ transfer agent and how does a registered shareholder contact the agent regarding account information?
A:   Computershare Investor Services, N.A.
Shareholder Investor Services
PO BOX 43078
Providence, RI 02940-3078
Phone: 781.575.2879
Computershare Investor Services Website
 
    Top
     
2.   Does Cardiogenesis offer a dividend reinvestment program (DRIP) for its common stock  shareholders?
A:   No.
    Top
     
3.   Does Cardiogenesis offer Direct Deposit of common stock dividends?
A:   No.
    Top
     
4.   Does Cardiogenesis offer a Direct Stock Purchase (DSP) program? .
A:   No.
    Top
     
5.   When does Cardiogenesis release earnings?
A:   Q1-Q3 - approx 4 weeks following quarter end, Q4 - 8 weeks following quarter end.
    Top
     
6.   When is Cardiogenesis' Annual Shareholders' Meeting?
A:   Typically in July
    Top
     
7.   When was the last stock split?
A:   Never.
    Top
     
8.   How many employees does Cardiogenesis have?
A:   30 (as of July 31, 2007)
    Top
     
9.   What is ticker symbol for Cardiogenesis common stock?
A:   CGCP.PK
    Top
     
10.   What year was Cardiogenesis incorporated and in what state?
A:   April 1989, California.
    Top
     
11.   How can I get a copy of Cardiogenesis annual report
A:   Request from Cardiogenesis Investor Relations Dept.
    Top
     
12.   When was Cardiogenesis' initial public offering?
A:   April 1996.
    Top
     
13.   Has Cardiogenesis held any subsequent offerings?
A:   Only private placements.
    Top
     
14.   What are the proceeds being used for from the secondary offering?
A:   Working capital, FDA clinical studies, R&D research projects and new product development.
    Top
     
15.   Are there any analysts currently following Cardiogenesis?
A:   Not at this time.
    Top
     
16.   What is the number of shares of common stock currently outstanding?
A:   Approximately 45 million.
    Top
     
17.   Who are Cardiogenesis' independent accountants?
A:   KMJ Corbin & Company LLP
    Top

 

Register for Company Alerts   |   Privacy Statement   |   Terms of Use   |   Ethics   |   Coronary Heart Disease Glossary